hoe 694 has been researched along with veratrine in 2 studies
| Studies (hoe 694) | Trials (hoe 694) | Recent Studies (post-2010) (hoe 694) | Studies (veratrine) | Trials (veratrine) | Recent Studies (post-2010) (veratrine) |
|---|---|---|---|---|---|
| 120 | 0 | 4 | 808 | 1 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| John, GW; Le Grand, B; Marty, A; Talmant, JM | 1 |
| Chattou, S; Coulombe, A; Diacono, J; Feuvray, D; John, G; Le Grand, B | 1 |
2 other study(ies) available for hoe 694 and veratrine
| Article | Year |
|---|---|
HOE 694 affords protection versus veratrine contractures in rat atria by Na+ channel blockade.
Topics: Action Potentials; Algorithms; Amiloride; Animals; Diuretics; Dose-Response Relationship, Drug; Guanidines; Heart Atria; Lethal Dose 50; Male; Myocardial Contraction; Rats; Rats, Wistar; Sodium Channels; Sodium-Hydrogen Exchangers; Sulfones; Veratrine | 1996 |
Slowly inactivating component of sodium current in ventricular myocytes is decreased by diabetes and partially inhibited by known Na(+)-H(+)Exchange blockers.
Topics: Amiloride; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Guanidines; Heart Ventricles; Lysophosphatidylcholines; Male; Myocardium; Patch-Clamp Techniques; Rats; Rats, Wistar; Sodium Channels; Sodium-Hydrogen Exchangers; Streptozocin; Sulfones; Tetrodotoxin; Veratrine | 2000 |